首页> 外文期刊>Saudi journal of kidney diseases and transplantation : >Gulf Cooperation Council-dialysis outcomes and practice patterns study: An overview of anemia management trends at the regional and country specific levels in the Gulf Cooperation Council countries
【24h】

Gulf Cooperation Council-dialysis outcomes and practice patterns study: An overview of anemia management trends at the regional and country specific levels in the Gulf Cooperation Council countries

机译:海湾合作委员会透析结果和实践模式研究:海湾合作委员会国家地区和国家特定级别的贫血管理趋势概述

获取原文
           

摘要

The Gulf Cooperation Council-Dialysis Outcomes and Practice Patterns Study (GCC-DOPPS) marks the joining of the six Gulf region countries including Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates to the main DOPPS study in 2012. The current review is a descriptive reporting on results related to the management of anemia from these countries. Our data demonstrate consistent anemia management patterns across the GCC countries allowing the achievement of international treatment levels. Overall, the majority of hemodialysis patients were prescribed appropriate erythropoiesis-stimulating agents (ESAs) and supplemental iron, enabling the attainment of mean hemoglobin (Hb) level of 10.9 g/dL. Comparisons of the individual country profiles reveal individual differences in the choice and mode of ESA and iron administration. However, all countries displayed good compliance with guideline recommendations. The same challenges as elsewhere are faced in the GCC, with respect to optimizing Hb levels and judiciously using ESA and iron supplements. Some opportunities exist for focused efforts to fine tune inter-facility variability in anemia management based on continued data tracking. The latter is vital in enabling adopting new trends to further improve not only anemia management but also the wholesome care of dialysis patients.
机译:海湾合作委员会透析结果和实践模式研究(GCC-DOPPS)标志着包括巴林,科威特,阿曼,卡塔尔,沙特阿拉伯和阿拉伯联合酋长国在内的六个海湾地区国家加入了2012年主要的DOPPS研究。本次审查是对这些国家与贫血管理有关的结果的描述性报告。我们的数据表明,在海湾合作委员会国家中,一致的贫血管理模式可实现国际治疗水平。总体而言,大多数血液透析患者都开有适当的促红细胞生成素(ESA)和补充铁的处方,使平均血红蛋白(Hb)水平达到10.9 g / dL。各个国家概况的比较揭示了ESA和铁管理的选择和模式方面的个体差异。但是,所有国家都表现出对准则建议的良好遵守。在优化Hb水平以及明智地使用ESA和铁补充剂方面,GCC面临着与其他地区一样的挑战。存在一些机会,可以根据持续的数据跟踪,集中精力来调整贫血管理中的机构间差异。后者对于采用新趋势来进一步改善贫血管理和透析患者的健康护理至关重要。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号